Orexo AB (publ) (ORX.ST)
SEK 14.88
(-5.46%)
SEK 14.88
(-5.46%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -3.73 SEK | 27.85% |
| 2022 | -5.17 SEK | 20.58% |
| 2021 | -6.51 SEK | -165.71% |
| 2020 | -2.45 SEK | -138.7% |
| 2019 | 6.33 SEK | 58.65% |
| 2018 | 3.99 SEK | 495.52% |
| 2017 | 0.67 SEK | -20.24% |
| 2016 | 0.84 SEK | 114.63% |
| 2015 | -5.74 SEK | -231.79% |
| 2014 | -1.73 SEK | 66.47% |
| 2013 | -5.16 SEK | -76.71% |
| 2012 | -2.92 SEK | 79.76% |
| 2011 | -14.43 SEK | -278.74% |
| 2010 | -3.81 SEK | 11.81% |
| 2009 | -4.32 SEK | 9.24% |
| 2008 | -4.76 SEK | 0.0% |
| 2007 | - SEK | 100.0% |
| 2006 | -2.46 SEK | 24.54% |
| 2005 | -3.26 SEK | 99.28% |
| 2004 | -450.66 SEK | 54.06% |
| 2003 | -980.88 SEK | -18.08% |
| 2002 | -830.66 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.26 SEK | 51.85% |
| 2024 Q2 | -1.04 SEK | -300.0% |
| 2024 Q3 | -1.21 SEK | -16.35% |
| 2023 Q3 | -0.97 SEK | -162.16% |
| 2023 Q4 | -0.54 SEK | 44.33% |
| 2023 FY | - SEK | 27.85% |
| 2023 Q2 | -0.37 SEK | 80.11% |
| 2023 Q1 | -1.86 SEK | 30.34% |
| 2022 Q1 | -0.69 SEK | 64.25% |
| 2022 Q2 | -1.04 SEK | -50.72% |
| 2022 Q3 | -0.77 SEK | 25.96% |
| 2022 Q4 | -2.67 SEK | -246.75% |
| 2022 FY | - SEK | 20.58% |
| 2021 FY | - SEK | -165.71% |
| 2021 Q1 | -0.92 SEK | 37.84% |
| 2021 Q2 | -2.15 SEK | -133.7% |
| 2021 Q4 | -1.93 SEK | -27.81% |
| 2021 Q3 | -1.51 SEK | 29.77% |
| 2020 Q3 | -2.45 SEK | -160.64% |
| 2020 Q1 | 2.38 SEK | 112.5% |
| 2020 FY | - SEK | -138.7% |
| 2020 Q2 | -0.94 SEK | -139.5% |
| 2020 Q4 | -1.48 SEK | 39.59% |
| 2019 Q2 | 1.54 SEK | 275.61% |
| 2019 Q3 | 3.22 SEK | 109.09% |
| 2019 Q4 | 1.12 SEK | -65.22% |
| 2019 FY | - SEK | 58.65% |
| 2019 Q1 | 0.41 SEK | -72.48% |
| 2018 Q3 | 1.80 SEK | 24.14% |
| 2018 FY | - SEK | 495.52% |
| 2018 Q2 | 1.45 SEK | 293.33% |
| 2018 Q4 | 1.49 SEK | -17.22% |
| 2018 Q1 | -0.75 SEK | -197.4% |
| 2017 Q3 | 0.82 SEK | 811.11% |
| 2017 Q2 | 0.09 SEK | 109.0% |
| 2017 Q1 | -1.00 SEK | -203.09% |
| 2017 FY | - SEK | -20.24% |
| 2017 Q4 | 0.77 SEK | -6.1% |
| 2016 FY | - SEK | 114.63% |
| 2016 Q3 | 1.04 SEK | 642.86% |
| 2016 Q2 | 0.14 SEK | 114.0% |
| 2016 Q1 | -1.00 SEK | 33.33% |
| 2016 Q4 | 0.97 SEK | -6.73% |
| 2015 FY | - SEK | -231.79% |
| 2015 Q1 | -0.45 SEK | -130.0% |
| 2015 Q2 | -2.46 SEK | -446.67% |
| 2015 Q3 | -1.33 SEK | 45.93% |
| 2015 Q4 | -1.50 SEK | -12.78% |
| 2014 Q2 | -1.58 SEK | -139.39% |
| 2014 Q4 | 1.50 SEK | 240.19% |
| 2014 FY | - SEK | 66.47% |
| 2014 Q3 | -1.07 SEK | 32.28% |
| 2014 Q1 | -0.66 SEK | 44.54% |
| 2013 Q1 | 0.95 SEK | 223.38% |
| 2013 Q2 | -4.00 SEK | -521.05% |
| 2013 Q4 | -1.19 SEK | -29.35% |
| 2013 Q3 | -0.92 SEK | 77.0% |
| 2013 FY | - SEK | -76.71% |
| 2012 FY | - SEK | 79.76% |
| 2012 Q4 | -0.77 SEK | 28.04% |
| 2012 Q2 | -0.56 SEK | -3.7% |
| 2012 Q3 | -1.07 SEK | -91.07% |
| 2012 Q1 | -0.54 SEK | 94.05% |
| 2011 FY | - SEK | -278.74% |
| 2011 Q4 | -9.07 SEK | -385.03% |
| 2011 Q3 | -1.87 SEK | -83.33% |
| 2011 Q2 | -1.02 SEK | 38.92% |
| 2011 Q1 | -1.67 SEK | -1935.16% |
| 2010 Q3 | -1.22 SEK | 19.21% |
| 2010 Q1 | -1.18 SEK | 52.42% |
| 2010 FY | - SEK | 11.81% |
| 2010 Q2 | -1.51 SEK | -27.97% |
| 2010 Q4 | 0.09 SEK | 107.46% |
| 2009 FY | - SEK | 9.24% |
| 2009 Q1 | 1.20 SEK | 281.82% |
| 2009 Q2 | -2.53 SEK | -310.83% |
| 2009 Q3 | -0.42 SEK | 83.4% |
| 2009 Q4 | -2.48 SEK | -490.48% |
| 2008 Q3 | 0.09 SEK | 0.0% |
| 2008 Q4 | -0.66 SEK | -833.33% |
| 2008 FY | - SEK | 0.0% |
| 2007 FY | - SEK | 100.0% |
| 2006 FY | - SEK | 24.54% |
| 2005 FY | - SEK | 99.28% |
| 2004 FY | - SEK | 54.06% |
| 2003 FY | - SEK | -18.08% |
| 2002 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AcuCort AB | -0.16 SEK | -2231.25% |
| AlzeCure Pharma AB (publ) | -0.60 SEK | -521.667% |
| BioGaia AB (publ) | 3.62 SEK | 203.039% |
| Enzymatica AB (publ) | -0.28 SEK | -1232.143% |
| Enorama Pharma AB (publ) | -1.61 SEK | -131.677% |
| Gabather AB (publ) | -0.65 SEK | -473.846% |
| Klaria Pharma Holding AB (publ.) | -0.36 SEK | -936.111% |
| Moberg Pharma AB (publ) | -1.33 SEK | -180.451% |
| Nanexa AB (publ) | -1.09 SEK | -242.202% |
| Newbury Pharmaceuticals AB (publ) | -0.72 SEK | -418.056% |
| ODI Pharma AB | 0.02 SEK | 16040.171% |
| Probi AB (publ) | 1.48 SEK | 352.027% |
| Swedencare AB (publ) | 0.37 SEK | 1108.108% |
| Swedish Orphan Biovitrum AB (publ) | 7.47 SEK | 149.933% |
| Toleranzia AB | -0.06 SEK | -6560.714% |
| Vivesto AB | -0.74 SEK | -404.054% |